Huang Wei, Li Cishan, Li Bing, Umekawa Midori, Yamamoto Kenji, Zhang Xinyu, Wang Lai-Xi
Institute of Human Virology and Department of Biochemistry & Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
J Am Chem Soc. 2009 Feb 18;131(6):2214-23. doi: 10.1021/ja8074677.
Homogeneous N-glycoproteins carrying defined natural N-glycans are essential for detailed structural and functional studies. The transglycosylation activity of the endo-beta-N-acetylglucosaminidases from Arthrobacter protophormiae (Endo-A) and Mucor hiemalis (Endo-M) holds great potential for glycoprotein synthesis, but the wild-type enzymes are not practical for making glycoproteins carrying native N-glycans because of their predominant activity for product hydrolysis. In this article, we report studies of two endoglycosidase-based glycosynthases, EndoM-N175A and EndoA-N171A, and their usefulness in constructing homogeneous N-glycoproteins carrying natural N-glycans. The oligosaccharide oxazoline corresponding to the biantennary complex-type N-glycan was synthesized and tested with the two glycosynthases. The EndoM-N175A mutant was able to efficiently transfer the complex-type glycan oxazoline to a GlcNAc peptide and GlcNAc-containing ribonuclease to form the corresponding homogeneous glycopeptide/glycoprotein. The EndoA-N171A mutant did not recognize the complex-type N-glycan oxazoline but could efficiently use the high-mannose-type glycan oxazoline for transglycosylation. These mutants possess the transglycosylation activity but lack the hydrolytic activity toward the product. Kinetic studies revealed that the dramatically enhanced synthetic efficiency of the EndoA-N171A mutant was due to the significantly reduced hydrolytic activity toward both the Man(9)GlcNAc oxazoline and the product as well as to its enhanced activity for transglycosylation. Thus, the two mutants described here represent the first endoglycosidase-based glycosynthases enabling a highly efficient synthesis of homogeneous natural N-glycoproteins.
携带特定天然 N-聚糖的均一 N-糖蛋白对于详细的结构和功能研究至关重要。来自原光节杆菌(内切酶 A)和冬生毛霉(内切酶 M)的内切β-N-乙酰氨基葡萄糖苷酶的转糖基化活性在糖蛋白合成方面具有巨大潜力,但野生型酶由于其对产物水解的主要活性,对于制备携带天然 N-聚糖的糖蛋白并不实用。在本文中,我们报道了两种基于内切糖苷酶的糖基合成酶 EndoM-N175A 和 EndoA-N171A 的研究,以及它们在构建携带天然 N-聚糖的均一 N-糖蛋白方面的用途。合成了与双天线复合型 N-聚糖对应的寡糖恶唑啉,并与这两种糖基合成酶进行了测试。EndoM-N175A 突变体能够有效地将复合型聚糖恶唑啉转移到 GlcNAc 肽和含 GlcNAc 的核糖核酸酶上,以形成相应的均一糖肽/糖蛋白。EndoA-N171A 突变体不识别复合型 N-聚糖恶唑啉,但可以有效地利用高甘露糖型聚糖恶唑啉进行转糖基化。这些突变体具有转糖基化活性,但对产物缺乏水解活性。动力学研究表明,EndoA-N171A 突变体合成效率的显著提高是由于其对 Man(9)GlcNAc 恶唑啉和产物的水解活性显著降低以及转糖基化活性增强。因此,本文描述的这两种突变体代表了首批基于内切糖苷酶的糖基合成酶,能够高效合成均一的天然 N-糖蛋白。